community download

Presentation: Immunome-Derived Vaccines

Vaccines evolve rapidly, as shown by the progress made in the industry in the past 100 years. Despite this progress, the vaccine industry continues to strive to improve vaccine safety, efficiency and efficacy.

Dr Timothy Messitt, Manager, Business Development, EpiVax, joined us at the World Vaccine Congress 2012 in Washington to present research into Immunome-derived vaccines, which at EpiVax they believe is the next wave of vaccine design:

• In silico approaches to vaccine design.
• Methods for moving vaccine science beyond traditional approaches to immunome-derived epitope-driven vaccines (ID-EDV)
• In vitro and in vivo case studies of the ID-EDV approach.

Why not download the full presentation and find out more about EpiVax and their Immunome-derived vaccines, for example, the development plans of a Multi-Pathogen Epitope-Driven Vaccine, which aims to contrast immunogenicity and efficacy of a multi-epitope vaccine with ‘whole antigen’ in HLA transgenic mice.

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*

Remember my details Information

Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Privacy statement »
Manage your email preferences »

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.